SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-103197
Filing Date
2024-04-19
Accepted
2024-04-19 19:09:50
Documents
2
Group Members
CHEN YUTCG CROSSOVER FUND I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G d829911dsc13g.htm SC 13G 68039
2 EX-99.1 d829911dex991.htm EX-99.1 4613
  Complete submission text file 0001193125-24-103197.txt   74219
Mailing Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301
Business Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301 650-798-5495
TCG Crossover GP I, LLC (Filed by) CIK: 0001839947 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Subject) CIK: 0001956827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94198 | Film No.: 24859241
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)